TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
43 hedge funds and large institutions have $184M invested in Talis Biomedical Corporation Common Stock in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 7 closing their positions.
Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
17
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$4.88M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$6.01M |
| 3 |
3
BlackRock
New York
|
$8.9M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$2.27M |
| 5 |
5
Alyeska Investment Group
Chicago,
Illinois
|
$1.1M |
